Literature DB >> 8626682

Refolding and oxidation of recombinant human stem cell factor produced in Escherichia coli.

M D Jones1, L O Narhi, W C Chang, H S Lu.   

Abstract

Oxidative folding of recombinant human stem cell factor (rhSCF) produced in Escherichia coli was investigated in vitro. Folding of denatured and reduced rhSCF involves at least five intermediate forms, I-1 to I-5, detectable by their differences in hydrophobicity using reverse-phase high performance liquid chromatography. Both I-1 and I-2 contain a native-like disulfide bond, Cys4-Cys89 and Cys43-Cys138, respectively, and I-3 forms a mispaired disulfide, Cys43-Cys89. These forms appear to reach steady state equilibrium and are important folding intermediates. I-1 was found to be the prominent intermediate that directly folds into native rhSCF (N); and the thermodynamically less stable I-2 favors rearrangment into I-1. I-3 may serve as an intermediate for disulfide rearrangment between I-1 and I-2. I-4 and I-5, which are disulfide-linked dimers, are in equilibrium with reduced rhSCF and other intermediates and may not play an important role in rhSCF folding. Both trifluoroacetic acid-trapped I-1 and I-2, after isolation by high performance liquid chromatography, proceed with the remaining oxidative folding process after reconstitution. Iodoacetate-trapped I-1 and I-2 contain low alpha-helical content and some tertiary structure, while I-3 and reduced rhSCF have little ordered structure. Gel filtration/light-scattering experiments indicate that reduced rhSCF and iodoacetate-trapped I-1, I-2, and I-3 exist as dimeric forms, indicating that rhSCF dimerization precedes formation of disulfide bonds. I-1, I-2, I-3, and the C43,138A analog lacking Cys43-Cys138 bond are not biologically active or exhibit significantly lower activity. The two disulfide bonds in rhSCF seem to be essential for the molecule to maintain an active conformation required for its receptor binding and biological activities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626682     DOI: 10.1074/jbc.271.19.11301

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Cloning of Soluble Human Stem Cell Factor in pET-26b(+) Vector.

Authors:  Salman Asghari; Mahmoud Shekari Khaniani; Masood Darabi; Sima Mansoori Derakhshan
Journal:  Adv Pharm Bull       Date:  2013-12-23

2.  Construction of pPIC9 Recombinant Vector Containing Human Stem Cell Factor.

Authors:  Behrooz Farhadi; Mahmoud Shekari Khaniani; Sima Mansoori Derakhshan
Journal:  Adv Pharm Bull       Date:  2013-08-20

3.  Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2.

Authors:  Celia Zazo Seco; Luciana Serrão de Castro; Josephine W van Nierop; Matías Morín; Shalini Jhangiani; Eva J J Verver; Margit Schraders; Nadine Maiwald; Mieke Wesdorp; Hanka Venselaar; Liesbeth Spruijt; Jaap Oostrik; Jeroen Schoots; Jeroen van Reeuwijk; Stefan H Lelieveld; Patrick L M Huygen; María Insenser; Ronald J C Admiraal; Ronald J E Pennings; Lies H Hoefsloot; Alejandro Arias-Vásquez; Joep de Ligt; Helger G Yntema; Joop H Jansen; Donna M Muzny; Gerwin Huls; Michelle M van Rossum; James R Lupski; Miguel Angel Moreno-Pelayo; Henricus P M Kunst; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2015-10-29       Impact factor: 11.025

4.  Novel Bacterial Production of Two Different Bioactive Forms of Human Stem-Cell Factor.

Authors:  Eunyoung Lee; Michelle Novais de Paula; Sangki Baek; Huynh Kim Khanh Ta; Minh Tan Nguyen; Taeck-Hyun Jeong; Chong Jai Kim; Yeon Jin Jang; Han Choe
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.